IBOV 171,906.72 ▲ 0.51% IPSA 11,537.98 ▲ 1.76% IPC MEX 66,105.23 ▲ 0.57% MERVAL 2,995,129 ▲ 2.81% COLCAP 2,510.72 ▲ 2.09% BVL PERÚ 60,222.25 ▼ 0.17% USD/BRL5.14▼ 0.31% USD/MXN16.95▲ 0.01% USD/CLP911.58▼ 0.37% USD/COP3,055▲ 0.40% USD/PEN3.35▼ 0.01% USD/ARS1,509▲ 0.63% USD/UYU40.18▼ 0.03% USD/PYG5,989▼ 0.11% USD/BOB11.44▲ 0.09% USD/DOP58.34▼ 0.53% USD/CRC446.05▼ 0.89% USD/GTQ7.62▼ 0.04% USD/HNL26.82▲ 0.02% USD/NIO36.62▲ 0.58% USD/VES783.11▲ 0.53% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD 157.28 — 0.00% USD/TTD6.72▲ 0.25% EUR/BRL6.01▲ 0.31% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73% IBOV 171,906.72 ▲ 0.51% IPSA 11,537.98 ▲ 1.76% IPC MEX 66,105.23 ▲ 0.57% MERVAL 2,995,129 ▲ 2.81% COLCAP 2,510.72 ▲ 2.09% BVL PERÚ 60,222.25 ▼ 0.17% USD/BRL 5.16 ▲ 0.01% USD/MXN 17.06 ▼ 0.24% USD/CLP 913.98 ▲ 0.04% USD/COP 3,140 ▲ 0.03% USD/PEN 3.36 ▼ 0.66% USD/ARS 1,493 ▲ 0.10% USD/UYU 40.27 ▲ 1.24% USD/PYG 5,939 ▲ 1.68% USD/BOB 11.64 ▼ 0.76% USD/DOP 58.34 ▲ 1.25% USD/CRC 445.92 ▲ 0.89% USD/GTQ 7.62 ▲ 2.21% USD/HNL 26.79 ▲ 1.57% USD/NIO 36.62 ▲ 0.69% USD/VES 762.44 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.28 — 0.00% USD/TTD 6.70 ▲ 0.61% EUR/BRL 5.95 ▲ 1.01% BRENT 88.88 ▼ 0.03% WTI 83.11 ▼ 0.11% IRON ORE 161.91 — — COPPER 6.61 ▲ 0.03% GOLD 4,461 ▲ 1.78% SILVER 65.59 ▲ 1.26% SOY 1,184 ▲ 3.20% CORN 480.50 ▲ 10.02% WHEAT 655.00 ▲ 3.93% COFFEE 317.25 ▼ 5.51% SUGAR 16.43 ▼ 1.79% ORANGE JUICE 138.55 ▼ 0.47% COTTON 85.03 ▲ 2.33% COCOA 5,719 ▲ 3.18% BEEF 223.60 ▼ 3.93% CATTLE 339.10 ▼ 3.16% LITHIUM 75.20 ▲ 1.47% PETR4 41.64 ▼ 0.05% VALE3 72.97 ▲ 0.83% ITUB4 38.60 ▼ 1.03% BBDC4 16.85 ▲ 0.36% ABEV3 14.89 ▼ 0.80% BBAS3 19.37 ▲ 0.47% B3SA3 14.26 ▼ 0.21% WEGE3 47.59 ▲ 0.49% PRIO3 59.14 ▼ 0.19% SUZB3 41.33 ▲ 2.35% RENT3 34.68 ▼ 0.09% AZZA3 15.89 ▼ 2.63% CSAN3 3.22 ▼ 1.83% RAIZ4 0.25 — 0.00% PCAR3 2.75 ▼ 0.36% GMAT3 3.65 ▼ 1.08% PSSA3 48.13 ▼ 0.54% CVCB3 1.33 ▼ 2.92% POSI3 3.36 ▲ 2.44% SLCE3 13.34 ▲ 0.30% NATU3 8.14 ▼ 0.73%
since 2009
Tuesday, August 25, 2026

Covid-19 Brazil

Brazil’s Petrobras prescribes Ivermectin to employees with Covid-19 – labor union

By · June 16, 2021 · 3 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

RIO DE JANEIRO, BRAZIL – The Petroleum Workers Federation (FUP) denounced that Petrobras (PETR3; PETR4) is prescribing Ivermectin for the treatment of its employees with Covid-19, according to a prescription given to infected workers or suspected of being infected by the disease.

Petrobras is prescribing Ivermectin to its employees. (Photo internet reproduction)
RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

The World Health Organization (W.H.O.) has rejected ivermectin for treating Covid-19 because in addition to being ineffective, it may have side effects. “Insistence on this treatment contravenes not only the World Health Organization protocols: the pharmaceutical company Merck itself, which manufactures the drug, declared in an official statement that, according to its scientists’ analysis, there is no efficacy in the use of the drug for Covid,” FUP alerts in a statement.

The state-owned company is allegedly in line with the federal government’s position, which, led by president Jair Bolsonaro, advocates the early treatment of Covid-19 using drugs rejected by the W.H.O. Ivermectin, for instance, is used in the treatment of parasites, such as lice and scabies.

The federation also criticized the quality of the masks that Petrobras has been distributing.

“In addition to prescribing drugs with no proven efficacy, the company refuses to supply PFF2 protection masks to all employees, contrary to the Labor Prosecutor’s Office and Fiocruz’s advice,” it said.

The organization also points out that Petrobras has also refused to test employees for Covid-19 iwhile on board offshore platforms (testing is only conducted before boarding), and that it does not respect social distancing in its activities.

According to the 61st Covid-19 Bulletin released on Monday, June 14, by the Ministry of Mines and Energy (MME), the number of deaths by Covid-19 at Petrobras has more than doubled in the last two and a half months, to 45 workers, and 7,205 have been infected by the disease, while 6,949 have recovered.

The other side

According to Petrobras, “there is no corporate guidance as to the drugs to be prescribed in case of Covid-19, or any other disease. The prescription of drugs for any disease is the choice and responsibility of the medical professional and this autonomy is assured by the Code of Medical Ethics.”

Also according to the company, Petrobras’ physicians have as their main attribution occupational health and, during the Covid-19 pandemic, they work in the development and monitoring of preventive measures.

“The prescription of drugs to treat Covid-19 is performed only in specific situations. The recommendation to seek the attending physician for treatment follow-up is always emphasized, whether in the public or private health care network,” it explained.

On the increase in deaths and infections by the disease, the company said that the recorded cases of infection follow a trend similar to national averages, and the diagnosis at Petrobras is more accurate, because employees are tested more often than the general population.

It also reported that it provides different types of masks depending on the type of task performed and the nature of activities. “Fabric or disposable masks with multiple layers, surgical masks, and PFF-2 type masks are used,” it said in a statement, stressing that it has adopted all protective measures for workers to prevent infection.

 

Live Company IntelligencePetroleo Brasileiro Petrobras SA ADR — the full investor dossierInside: live share price, market cap, three-year financials, valuation, ESG and peer benchmarks — plus the latest Rio Times coverage.
P
◆ Live Company Intelligence
Petroleo Brasileiro Petrobras
NYSE: PBRPETR4EnergyOil & Gas Integrated43,199 employees
$123.41B
Market cap
Analyst target $22.03

Wall Street view

4.4Buy/ 5
11 Buy3 Hold0 Sell
Avg. price target $22.03  ·  +31% vs 200-day

Valuation & profitability

Market cap$123.41B
Revenue (TTM)$548.49B
P / E ratio4.8
Profit margin24.3%
Return on equity30.3%

Price & risk

52-wk low
$10.97
52-wk high
$22.07
Beta (volatility)-0.22
200-day average$16.75

Revenue trend · 6y

20202025
Latest $88.10B

Ownership

Institutions22.3%
Shares outstanding3.72B
Top holderGQG Partners LLC
Institutional holders5+ funds

Dividend

Yield19.3%
Payout ratio28.3%
Fwd. annual$1.69
What Petroleo Brasileiro Petrobras does. Petróleo Brasileiro S.A. – Petrobras explores, produces, and sells oil and gas in Brazil, China, the United States, the Americas, Asia, Europe, Singapore, and internationally. It operates through three segments: Exploration and Production; Refining, Transportation & Marketing; and Gas & Low Carbon Energies. The Exploration and Production segment explores, develops, and produces…
Data: RT fundamentals (PBR.US) · figures in USD · as of 25 Aug 2026More company intelligence →

This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.